Form 4 Filing for 10x Genomics, Inc. - Kosaraju Sridhar

This filing details transactions made by Kosaraju Sridhar, a director at 10x Genomics, Inc. On June 4, 2026, Sridhar acquired 8,829 shares of Class A Common Stock through a transaction coded as "A", with a price of $0.0 per share. Following this transaction, Sridhar holds 65,278 shares. Additionally, the filing indicates that 3,000 shares are held indirectly through the Kosaraju Family Trust. The filing also includes a Power of Attorney document, appointing Randy Wu and James Bryant as attorneys-in-fact to handle SEC filings on behalf of Sridhar Kosaraju. This power of attorney remains in effect until Sridhar is no longer required to file under Section 16 of the Securities Exchange Act.